Linear shear conditioning improves vascular graft retention of adipose-derived stem cells by upregulation of the alpha5beta1 integrin.
Use of adult adipose-derived stem cells (ASCs) as endothelial cell substitutes in vascular tissue engineering is attractive because of their availability. However, when seeded onto decellularized vascular scaffolding and exposed to physiological fluid shear force, ASCs are physically separated from the graft lumen. Herein we have investigated methods of increasing initial ASC attachment using luminal precoats and a novel protocol for the gradual introduction of shear stress to optimize ASC retention. Fibronectin coating of the graft lumen increased ASC attachment by nearly sixfold compared with negative controls. Gradual introduction of near physiological fluid shear stress using a novel bioreactor whereby flow rate was increased every second at a rate of 1.5 dynes/cm(2) per day resulted in complete luminal coverage compared with near complete cell loss following conventional daily abrupt increases. An upregulation of the alpha(5)beta(1) integrin was evinced following exposure to shear stress, which accounts for the observed increase in ASC retention on the graft lumen. These results indicated a novel method for seeding, conditioning, and retaining of adult stem cells on a decellularized vein scaffold within a high-shear stress microenvironment.
McIlhenny
Stephen E
SE
Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Hager
Eric S
ES
Grabo
Daniel J
DJ
DiMatteo
Christopher
C
Shapiro
Irving M
IM
Tulenko
Thomas N
TN
DiMuzio
Paul J
PJ
D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism*; D053687:Adult Stem Cells / Q000166:cytology / Q000378:metabolism*; D019149:Bioreactors; D002448:Cell Adhesion; D018929:Cell Culture Techniques; D006801:Humans; D039081:Integrin alpha5beta1 / Q000096:biosynthesis*; D012501:Saphenous Vein; D013312:Stress, Physiological; D015854:Up-Regulation
D039081:Integrin alpha5beta1
Curr Pharm Biotechnol. 2007 Feb;8(1):43-50
17311552
J Surg Res. 2009 Mar;152(1):157-66
19883577
Circulation. 1995 Dec 15;92(12):3513-9
8521574
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1042-6
11158591
Am J Physiol Heart Circ Physiol. 2000 May;278(5):H1537-44
10775131
J Surg Res. 2005 Nov;129(1):17-23
16139306
Differentiation. 2007 Jan;75(1):12-23
17244018
Biochem Biophys Res Commun. 2005 Jul 1;332(2):370-9
15896706
FASEB J. 2008 Jun;22(6):2084-9
18203957
N Engl J Med. 2007 Oct 4;357(14):1451-3
17914054
Circulation. 2004 Feb 10;109(5):656-63
14734516
Annu Rev Biomed Eng. 1999;1:299-329
11701491
Ann Thorac Surg. 1998 May;65(5):1442-4
9594884
Genome Biol. 2007;8(5):215
17543136
J Orthop Res. 2003 Jul;21(4):622-9
12798061
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006406
19160282
J Vasc Surg. 2004 Jul;40(1):146-53
15218475
J Vasc Surg. 1986 Jan;3(1):58-64
3079841
J Biol Chem. 2002 Sep 20;277(38):34808-14
12093818
Surgery. 1979 Dec;86(6):836-51
515951
J Appl Physiol (1985). 2007 Mar;102(3):847-52
17158243
Biomaterials. 2009 Mar;30(8):1542-50
19111338
Surgery. 1995 Mar;117(3):334-9
7878541
Vascular. 2006 Nov-Dec;14(6):338-42
17150154
FASEB J. 1998 Jan;12(1):43-5
9438409
Tissue Eng. 2007 Aug;13(8):1799-808
17518736
Circulation. 2004 Jul 20;110(3):349-55
15238461
J Vasc Surg. 1988 Oct;8(4):476-82
3172385
Biomaterials. 2007 Jan;28(3):486-95
17034847
J Biomed Mater Res B Appl Biomater. 2008 May;85(2):537-46
18076094
J Cell Mol Med. 2007 Jan-Feb;11(1):21-38
17367499
Clin Pharmacol Ther. 2007 Sep;82(3):252-64
17671448
J Vasc Surg. 2007 Dec;46(6):1160-6
17920227
Stem Cells. 2006 Nov;24(11):2319-45
16794264
FASEB J. 1998 Jan;12(1):47-56
9438410
Biotechnol Appl Biochem. 2004 Apr;39(Pt 2):151-7
15032735
J Vasc Surg. 1986 Feb;3(2):264-72
3944930
Artif Organs. 2006 Apr;30(4):242-9
16643382
J Vasc Surg. 2007 Jun;45 Suppl A:A74-81
17544027
J Vasc Surg. 2007 Jun;45 Suppl A:A99-103
17544030
Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):389-95
17589429
J Vasc Surg. 1992 Jun;15(6):1010-7
1597883
J Vasc Surg. 1999 Jan;29(1):157-67
9882800